Efficacy and Safety of Tafolecimab in Chinese Patients With Non-Familial Hypercholesterolemia (CREDIT-1): A 48-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

被引:0
|
作者
Huo, Yong
Li, Yong
Zhang, Ping
Deng, Huan
Li, Haoyu
An, Pei
Xue, Fengtai
Yu, Zhongxun
Ma, Qingyang
Qi, Litong
Chen, Beijian
Lian, Qiufang
Lu, Di
Qian, Lei
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A10111
引用
收藏
页数:3
相关论文
共 50 条
  • [31] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
  • [32] Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
    Ji, Linong
    Lu, Jinmiao
    Gao, Leili
    Ying, Changjiang
    Sun, Jiao
    Han, Jie
    Zhao, Wenhua
    Gao, Yunming
    Wang, Kun
    Zheng, Xin
    Xie, Daosheng
    Ding, Juping
    Zhao, Jiahong
    Yu, Qiang
    Wang, Tong
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3671 - 3681
  • [33] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
    McDonald, C.
    Wu, S.
    Gulati, S.
    Komaki, H.
    Ruiz-Garcia, M.
    Kostera-Pruszczyk, A.
    Vlodavets, D.
    Chae, J.
    Jong, Y.
    Karachunski, P.
    Statland, J.
    Lorentzos, M.
    Penematsa, V
    Chou, C.
    Lin, M.
    Werner, C.
    Trifillis, P.
    Gordon, G.
    Klein, M.
    NEUROMUSCULAR DISORDERS, 2022, 32
  • [34] Safety and Efficacy of Ataluren in nmDMD Patients from Study 041, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    McDonald, Craig M.
    Wu, Shiwen
    Gulati, Sheffali
    Komaki, Hirofumi
    Escobar, Rosa E.
    Kostera-Pruszczyk, Anna
    Vlodavets, Dmitry
    Chae, Jong-Hee
    Jong, Yuh-Jyh
    Karachunski, Peter
    Statland, Jeffrey
    Lorentzos, Michelle
    Penematsa, Vinay
    Chou, Connie
    Lin, Min
    Werner, Christian
    Trifillis, Panayiota
    Gordon, Gregory
    Koladicz, Karyn
    Mastrandrea, Nicholas
    Klein, Matthew
    NEUROLOGY, 2023, 100 (17)
  • [35] A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients
    Liu, Quanzhong
    Chen, Haibo
    Xi, Liyan
    Hong, Zhen
    He, Li
    Fu, Yi
    Fang, Hong
    Shang, Ningxiu
    Yan, Ping
    Fan, Dongsheng
    PAIN PRACTICE, 2017, 17 (01) : 62 - 69
  • [36] Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: A 12-week, randomized, double-blind, placebo-controlled trial
    Malhotra, AK
    Keefe, R
    Meltzer, H
    Kane, J
    Murthy, A
    Sovel, M
    Xu, YK
    Gold, L
    Goldman, R
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S171 - S171
  • [37] The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial
    McMurray, John J. V.
    Freeman, Mason W.
    Massaro, Joe
    Solomon, Scott
    Lock, Paul
    Riddle, Matthew C.
    Halvorsen, Yuan-Di C.
    DIABETES, 2020, 69
  • [38] Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial
    Arnold, Lesley M.
    Hirsch, Ian
    Sanders, Paul
    Ellis, Amanda
    Hughes, Bernadette
    ARTHRITIS AND RHEUMATISM, 2012, 64 (07): : 2387 - 2397
  • [39] Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12-week, Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial
    Chey, William D.
    Lembo, Anthony J.
    Korner, Paul
    Yan, Andrew
    Rosenbaum, David P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S226 - S227
  • [40] Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
    Campillo, Jeremy T.
    Bikita, Paul
    Hemilembolo, Marlhand
    Louya, Frederic
    Missamou, Francois
    Pion, Sebastien D. S.
    Boussinesq, Michel
    Chesnais, CedricB
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 19 - 27